Gaush Meditech Ltd (FRA:F7Y)
Germany · Delayed Price · Currency is EUR 0.9800
-0.0150 (-1.51%)
At close: Sep 26, 2025
Gaush Meditech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | 101.89 | 92.39 | 173.52 | -349.62 | -190.45 | 99.37 | Upgrade |
Depreciation & Amortization | 84.03 | 80.6 | 74.69 | 64.63 | 58.84 | 12.15 | Upgrade |
Other Amortization | 1.34 | 1.34 | 1.28 | 1.12 | 1.22 | 0.19 | Upgrade |
Loss (Gain) From Sale of Assets | 0.58 | 0.68 | -0.15 | 0.67 | 0.05 | 0.14 | Upgrade |
Asset Writedown & Restructuring Costs | 23.26 | 23.26 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -5.76 | -3.72 | -3.96 | -0.01 | -0.09 | -2.27 | Upgrade |
Provision & Write-off of Bad Debts | -0.59 | -0.56 | -1.24 | -2.24 | 4.76 | 0.55 | Upgrade |
Other Operating Activities | 0.28 | 17.23 | 33.51 | 501.67 | 365.18 | 30.76 | Upgrade |
Change in Accounts Receivable | -24.72 | -16.43 | 19.68 | 8.26 | 20.49 | 28.57 | Upgrade |
Change in Inventory | 13.23 | -5.11 | -48.74 | -41.78 | 38.59 | -38.19 | Upgrade |
Change in Accounts Payable | -42.14 | -19.67 | 22.1 | -4.18 | -42.57 | -10.6 | Upgrade |
Change in Unearned Revenue | -19.25 | -21.71 | -7.51 | 39.8 | -27.6 | 17.38 | Upgrade |
Change in Other Net Operating Assets | 10.42 | -40.53 | -14.14 | -4.86 | -68.64 | -8.03 | Upgrade |
Operating Cash Flow | 142.55 | 107.78 | 249.04 | 234.42 | 164.49 | 130 | Upgrade |
Operating Cash Flow Growth | 12.23% | -56.72% | 6.24% | 42.52% | 26.53% | -24.00% | Upgrade |
Capital Expenditures | -17.4 | -14.67 | -34.92 | -45.4 | -26.55 | -1.77 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0 | 0.01 | - | - | - | Upgrade |
Cash Acquisitions | -25.64 | -23.79 | -9.4 | - | 105.77 | -1,201 | Upgrade |
Sale (Purchase) of Intangibles | -64.42 | -66.55 | -10.67 | -2.62 | -1.5 | -0.05 | Upgrade |
Investment in Securities | 100.5 | 80.19 | -81.11 | -92.7 | - | 199.57 | Upgrade |
Other Investing Activities | 43.61 | 43.35 | -31.55 | 4.68 | 2.11 | 5.4 | Upgrade |
Investing Cash Flow | 36.66 | 18.55 | -167.65 | -136.04 | 79.84 | -998.02 | Upgrade |
Long-Term Debt Issued | - | 27.52 | 7.92 | 57.72 | 66.08 | 937.38 | Upgrade |
Long-Term Debt Repaid | - | -135.56 | -153.08 | -339.94 | -104.96 | -78.86 | Upgrade |
Net Debt Issued (Repaid) | -211.75 | -108.04 | -145.16 | -282.21 | -38.88 | 858.52 | Upgrade |
Issuance of Common Stock | - | - | 1.55 | 327.8 | 29.07 | - | Upgrade |
Repurchase of Common Stock | -21.73 | -12.58 | - | - | -489.73 | - | Upgrade |
Common Dividends Paid | -148.56 | -148.56 | - | - | - | - | Upgrade |
Other Financing Activities | -28.19 | -33.93 | -46.32 | -42.51 | -86.73 | -2.17 | Upgrade |
Financing Cash Flow | -410.22 | -303.09 | -189.94 | 3.08 | 72.84 | 856.36 | Upgrade |
Foreign Exchange Rate Adjustments | 7.35 | -20.5 | 5.72 | 11.07 | -15.66 | -13.61 | Upgrade |
Net Cash Flow | -223.65 | -197.26 | -102.83 | 112.53 | 301.51 | -25.27 | Upgrade |
Free Cash Flow | 125.16 | 93.12 | 214.11 | 189.03 | 137.94 | 128.23 | Upgrade |
Free Cash Flow Growth | 39.45% | -56.51% | 13.27% | 37.04% | 7.57% | -23.21% | Upgrade |
Free Cash Flow Margin | 8.70% | 6.52% | 15.23% | 15.08% | 10.63% | 13.33% | Upgrade |
Free Cash Flow Per Share | 0.85 | 0.63 | 1.45 | 1.95 | 1.44 | 1.22 | Upgrade |
Cash Interest Paid | 24.3 | 33.38 | 42.27 | 38.82 | 76.09 | 2.17 | Upgrade |
Cash Income Tax Paid | 91.59 | 89.71 | 85.47 | 94.49 | 97.43 | 62.48 | Upgrade |
Levered Free Cash Flow | -114.97 | -25.7 | 123.94 | 137.2 | -9.58 | 140.04 | Upgrade |
Unlevered Free Cash Flow | -98.31 | -2.76 | 155.56 | 163.87 | 42.63 | 141.96 | Upgrade |
Change in Working Capital | -62.47 | -103.44 | -28.62 | -2.76 | -79.74 | -10.87 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.